These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6344160)

  • 41. Beta2-glycoprotein-I plasma levels in liver cirrhosis.
    Gries A; Putz-Bankuti C; Stauber RE; Haditsch B; Stojakovic T
    Clin Chim Acta; 2009 May; 403(1-2):257-8. PubMed ID: 19275896
    [No Abstract]   [Full Text] [Related]  

  • 42. [Glucagon and lipid metabolism. I. Changes in total blood cholesterol and in its fractions due to glucagon stimulation].
    Bianucci G; Spinelli P; Corsi C
    Riv Crit Clin Med; 1965 Aug; 65(4):428-61. PubMed ID: 5886503
    [No Abstract]   [Full Text] [Related]  

  • 43. Carbohydrate metabolism studies in cirrhosis of the liver.
    Carneiro de Moura M; Ginestal Cruz A
    Am J Dig Dis; 1968 Oct; 13(10):891-906. PubMed ID: 5680902
    [No Abstract]   [Full Text] [Related]  

  • 44. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.
    Bahr MJ; Boeker KH; Manns MP; Tietge UJ
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):60-5. PubMed ID: 18466349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Carbohydrate metabolism in liver cirrhosis. II. Insulinemia following loading with glucose alone and in combination with glucagon and tolbutamide].
    Smoczyński M
    Pol Arch Med Wewn; 1975 Nov; 54(5):445-53. PubMed ID: 1197058
    [No Abstract]   [Full Text] [Related]  

  • 46. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
    Tietge UJ; Böker KH; Manns MP; Bahr MJ
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.
    Caronia S; Taylor K; Pagliaro L; Carr C; Palazzo U; Petrik J; O'Rahilly S; Shore S; Tom BD; Alexander GJ
    Hepatology; 1999 Oct; 30(4):1059-63. PubMed ID: 10498660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of insulin sensitivity based on a fasting blood sample in men with liver cirrhosis before and after liver transplantation.
    Perseghin G; Caumo A; Mazzaferro V; Pulvirenti A; Piceni Sereni L; Romito R; Lattuada G; Coppa J; Costantino F; Regalia E; Luzi L
    Transplantation; 2003 Aug; 76(4):697-702. PubMed ID: 12973112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Changes in hydrocarbon metabolism in hepatic cirrhosis. VI. HGH].
    Santolaria Fernández F; González García C; González Reimers E; Pérez Labajos P; Jorge Hernández J; Batista López N; Hernández Nieto L; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1983 Jun; 63(6):525-33. PubMed ID: 6878841
    [No Abstract]   [Full Text] [Related]  

  • 50. Carbohydrate metabolism in parenteral nutrition.
    Ohyanagi H
    Nutrition; 1994; 10(5 Suppl):517-8. PubMed ID: 7827430
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hepatic injuries in diabetic patients (fat infiltration, fibrosis and cirrhosis)].
    Teitelbaum H; Costa JA
    Medicina (B Aires); 1967; 27(2):88-92. PubMed ID: 5600650
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intestinal absorption of carbohydrates in liver cirrhosis without ascites following Botkin's disease].
    Geller LI; Kozlova ZP
    Vopr Pitan; 1971; 30(3):79-80. PubMed ID: 5146699
    [No Abstract]   [Full Text] [Related]  

  • 53. [Glucagon and lipid metabolism. II. Effects of glucagon on the blood level of lipoproteins and on the behavior of the Kunkel reaction to phenol. (Statistical observations on the biologic significance of the turbidimetric test)].
    Bianucci G; Corsi C; Spinelli P; Biddau A
    Riv Crit Clin Med; 1965 Oct; 65(5):507-22. PubMed ID: 5885541
    [No Abstract]   [Full Text] [Related]  

  • 54. [A clinical analysis of liver disease patients with abnormal glucose metabolism].
    Zhang X; Shen W; Shen DM
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):289-92. PubMed ID: 16635301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hepatologic problems in diabetes].
    Kubicki S
    Pol Tyg Lek; 1969 Jan; 24(2):60-3. PubMed ID: 4894577
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum thrombopoietin levels in thrombocytopenic patients with liver cirrhosis.
    Vyzantiadis T; Theodoridou S; Giouleme O; Evgenidis N; Vyzantiadis A; Garipidou V
    Haematologica; 2002 Aug; 87(8):890-1. PubMed ID: 12161370
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical studies on liver cirrhosis. VIII. Relation of liver cirrhosis to carbohydrate metabolism].
    FALCK I; BRUSCHKE G
    Z Gesamte Inn Med; 1958 Aug; 13(15):539-42. PubMed ID: 13593535
    [No Abstract]   [Full Text] [Related]  

  • 58. [Decrease of insulin resistance after splenectomy in a diabetic patient with liver cirrhosis and portal hypertension. Physiopathologic evaluation].
    Moro E; Pais M; Benvegnù M; Ferrari M; Bittolo Bon G
    Minerva Gastroenterol Dietol; 1994 Dec; 40(4):213-8. PubMed ID: 7849151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking Belgium.
    Buysschaert M; Paris I; Selvais P; Hermans MP
    Diabetes Metab; 1997 Sep; 23(4):308-13. PubMed ID: 9342544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.